KLK3 and prostate carcinoma: In the total group of patients with Gleason score 7 (n = 270), median age was 62 (range 47–74), median PSA 18.0 ng/mL (range 0.7–71), median tumor size 23 mm, 22% experienced CF and 9% were dead of prostate cancer.